Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Custom Research Competitive Landscape Industry News FAQ
On This Report

Mobile ECG Devices Market Size & Growth Forecast 2027–2036, By Segments (End-use, Modality), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14632| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Mobile ECG Devices Market size was worth USD 3.4 billion in 2026 and is expected to grow at a 11.12% CAGR between 2027 and 2036, surpassing USD 9.76 billion by 2036. The industry revenue for 2027 is assessed at USD 3.72 billion.

Base Year Value (2026)
USD 3.4 billion
CAGR (2027-2036)
11.12%
Forecast Year Value (2036)
USD 9.76 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Mobile ECG Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 51.41% share in 2026 due to mature connected healthcare infrastructure, widespread remote cardiac monitoring, and strong integration of portable ECG devices into clinical and home-based care.
  • Asia Pacific is projected to grow at a 12.99% CAGR, supported by expanding digital health services, greater healthcare technology access, and rising demand for flexible cardiac monitoring beyond hospitals.

Segment Momentum

  • Hospitals and Diagnostic Centers accounted for 51.62% of the market in 2026 due to high cardiac assessment volumes, structured diagnostic workflows, and access to trained clinicians for reliable ECG evaluation.
  • Band devices are the fastest-growing modality because they enable continuous, wearable ECG monitoring during daily activities, offering greater convenience than intermittent handheld assessments.

Market Expansion Drivers

  • Rising cardiac arrhythmia prevalence and aging population driving remote cardiac monitoring demand.
  • Integration of wearable technologies and mobile health platforms enabling continuous ECG tracking.
  • Expansion of telemedicine and home-based cardiac care accelerating device adoption.

Leading Market Participants

  • Leading companies in the mobile ECG devices market include Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Medtronic plc (Ireland), iRhythm Technologies, Inc. (United States), Nihon Kohden Corporation (Japan), Omron Healthcare Co., Ltd. (Japan), AliveCor, Inc. (United States), Withings S.A. (France), EMAY Ltd. (China), Dr Trust (India).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 3.4 billion
  • 2027 Estimated Market Size: USD 3.72 billion.
  • Projected Market Size: USD 9.76 billion by 2036
  • Growth Forecast: 11.12% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals and Diagnostic Centers (End-use) | Handheld (Modality)
  • Emerging Opportunity Segment: Homecare (End-use) | Band (Modality)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising cardiac arrhythmia prevalence and aging population driving remote cardiac monitoring demand

Increasing prevalence of cardiac arrhythmias and the growing needs of older populations will drive the mobile ECG devices market as healthcare providers seek more accessible approaches to cardiac monitoring. Remote monitoring capabilities enable ECG information to be captured outside conventional clinical settings, supporting ongoing observation of patients who require closer assessment of cardiac activity.

Integration of wearable technologies and mobile health platforms enabling continuous ECG tracking

Integration with wearable technologies and mobile health platforms will propel the mobile ECG devices market by making ECG monitoring more continuous and connected. These technologies allow cardiac data to be captured through portable devices and incorporated into digital health workflows, supporting convenient monitoring while giving users and healthcare providers greater access to ongoing cardiac information.

Expansion of telemedicine and home-based cardiac care accelerating device adoption

Growth in telemedicine and home-based cardiac care will boost mobile ECG devices market adoption by shifting portions of cardiac monitoring beyond traditional healthcare facilities. Portable ECG solutions support remote care models by allowing patients to undergo monitoring from home while healthcare providers incorporate device-generated cardiac information into digitally enabled consultations and ongoing care processes.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Growing prevalence of cardiovascular diseases 4.50% Short term (≤ 2 yrs) North America, Europe (spillover: Asia Pacific) High Fast
Adoption of portable ECG devices in hospitals and clinics 4.00% Medium term (2–5 yrs) Europe, Asia Pacific (spillover: North America) Medium Moderate
Integration with telemedicine and remote patient monitoring 3.10% Long term (5+ yrs) North America, Europe (spillover: Asia Pacific) Medium Slow
Rising cardiac arrhythmia prevalence and aging population driving remote cardiac monitoring demand 2.10% High North America, Europe High Near Term
Integration of wearable technologies and mobile health platforms enabling continuous ECG tracking 1.80% High North America, Asia Pacific High Mid Term
Expansion of telemedicine and home-based cardiac care accelerating device adoption 1.50% High Asia Pacific, Europe High Mid Term

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Mobile ECG Devices Market
Largest Region
North America
51.41% Market Share in 2026

North America (Largest Region)

Holding the largest share of the mobile ECG devices market at 51.41% in 2026, North America benefits from advanced digital healthcare infrastructure, widespread adoption of remote monitoring, and strong demand for convenient cardiac assessment solutions. Healthcare providers and patients are increasingly embracing connected devices that enable cardiac information to be captured outside conventional clinical environments, supporting earlier identification of irregularities and more continuous disease management. The region's established telehealth ecosystem, high acceptance of wearable and portable medical technologies, and emphasis on preventive care further support adoption. Integration of mobile ECG solutions with digital health platforms and electronic clinical workflows is also improving the ability of healthcare professionals to review cardiac information remotely, strengthening the market's regional foundation.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is projected to be the fastest-growing region, driven by expanding healthcare access, increasing awareness of cardiovascular health, and rapid adoption of connected medical technologies. Growing smartphone penetration and improvements in digital health infrastructure are creating favorable conditions for portable ECG solutions that can extend cardiac monitoring beyond traditional healthcare settings. The rising focus on preventive healthcare and remote patient management is encouraging demand from both healthcare providers and consumers, particularly where access to specialized cardiac services remains uneven. Investments in telemedicine, connected diagnostics, and digitally enabled healthcare delivery are further supporting adoption, while increasing acceptance of home-based monitoring is creating additional opportunities for mobile ECG device deployment.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
🔒 Need data on a specific country or region?. Individual country/region reports are available at discounted pricing. Inquire Before Buying
Country Insights

Key Country Insights

Germany 🇩🇪

Clinical Accuracy Focus

Germany prioritizes mobile ECG devices that deliver reliable diagnostic performance while integrating with established healthcare workflows. Demand is supported by physician confidence in validated monitoring technologies for outpatient cardiac assessment.

France 🇫🇷

Preventive Cardiac Screening

France supports mobile ECG deployment across preventive cardiology and ambulatory monitoring programs. Healthcare providers increasingly utilize portable diagnostic tools to improve early detection and continuity of cardiovascular care.

Italy 🇮🇹

Ambulatory Monitoring Expansion

Italy advances the use of mobile ECG devices across outpatient cardiology services and home-based patient monitoring. Clinical demand centers on practical, easy-to-use solutions that support long-term rhythm assessment and follow-up care.

Japan 🇯🇵

Aging Care Solutions

Japan emphasizes mobile ECG devices that enable continuous cardiac monitoring for an aging population with growing cardiovascular care needs. Healthcare providers value compact, user-friendly systems that support early rhythm detection outside hospital settings.

South Korea 🇰🇷

Digital Health Connectivity

South Korea encourages adoption of mobile ECG devices integrated with connected health platforms and telemedicine services. Manufacturers focus on AI-assisted analysis, wireless connectivity, and efficient data sharing with healthcare professionals.

United States 🇺🇸

Remote Cardiac Monitoring

The U.S. mobile ECG devices market is driven by expanding remote patient monitoring and digital health adoption. Healthcare providers increasingly integrate portable ECG solutions into chronic cardiac care, preventive screening, and virtual care programs.

Segment Analysis

Segment Leadership and Growth Trends

Mobile ECG Devices Market Share (%), by End-use, 2026

Hospitals and Diagnostic Centers
Homecare
Ambulatory Care

Go beyond the chart, access full insights & data tables

Request Free Sample Report

End-use Segment Analysis: Hospitals and Diagnostic Centers (Largest Segment) vs Homecare (Fastest-Growing Segment)

Hospitals and diagnostic centers held the largest share of the mobile ECG devices market, accounting for 51.62% in 2026. Their leading position is supported by the continued need for reliable cardiac monitoring and diagnostic assessment within established clinical settings. These facilities can integrate mobile ECG devices into routine cardiac evaluations, emergency assessment, and follow-up care, while trained healthcare professionals can interpret recorded cardiac data and determine appropriate interventions. The concentration of diagnostic infrastructure and growing emphasis on timely cardiovascular assessment further sustains demand from hospitals and diagnostic centers.

Homecare is emerging as the fastest-growing end-use segment as cardiac monitoring increasingly shifts toward more convenient and patient-centered care environments. Mobile ECG devices enable individuals to record cardiac activity outside conventional healthcare facilities, supporting remote monitoring and follow-up for patients requiring recurring assessment. Their portability and ease of use can also facilitate earlier identification of irregular cardiac activity and reduce dependence on frequent in-person visits. The broader adoption of remote healthcare and connected monitoring is therefore strengthening the role of homecare in mobile ECG applications.

Modality Segment Analysis: Handheld (Largest Segment) vs Band (Fastest-Growing Segment)

In the mobile ECG devices market, handheld devices represented the largest modality segment with a 43.67% share in 2026. Their position is supported by a combination of portability, straightforward operation, and suitability for rapid cardiac assessments. Handheld ECG devices can be used across clinical and mobile care environments, allowing healthcare professionals and patients to capture cardiac readings without relying exclusively on conventional stationary equipment. Their practical form factor and expanding use in decentralized monitoring contribute to sustained demand for this modality.

Band-based ECG devices are gaining momentum as the fastest-growing modality because they integrate cardiac monitoring into wearable formats that can support more continuous and convenient health tracking. The ability to collect ECG information while users continue normal daily activities makes bands particularly relevant to remote monitoring and preventive care. Increasing consumer interest in wearable health technologies, combined with demand for unobtrusive monitoring solutions, is encouraging broader adoption of band-based ECG devices and expanding their role in mobile cardiac care.

Segment Sub-Segment Largest Segment Fastest Growing
End-use Hospitals and Diagnostic Centers, Ambulatory Care, Homecare Hospitals and Diagnostic Centers Homecare
Modality Pen, Band, Handheld, Others Handheld Band
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the mobile ECG devices market:

1. Koninklijke Philips N.V. (Netherlands)

2. GE HealthCare Technologies Inc. (United States)

3. Medtronic plc (Ireland)

4. iRhythm Technologies Inc. (United States)

5. Nihon Kohden Corporation (Japan)

6. Omron Healthcare Co. Ltd. (Japan)

7. AliveCor Inc. (United States)

8. Withings S.A. (France)

9. EMAY Ltd. (China)

10. Dr Trust (India)

Increasing demand for remote cardiac monitoring is driving the mobile ECG devices market, with continuous innovation in wearable technologies, wireless connectivity, and AI-assisted ECG interpretation. Product advancements are enabling earlier diagnosis and more convenient long-term cardiovascular monitoring.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Koninklijke Philips N.V. (Netherlands)
GE HealthCare Technologies Inc. (United States)
Medtronic plc (Ireland)
iRhythm Technologies Inc. (United States)
Nihon Kohden Corporation (Japan)
Omron Healthcare Co. Ltd. (Japan)
AliveCor Inc. (United States)
Withings S.A. (France)
EMAY Ltd. (China)
Dr Trust (India).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
InfoBionic.Ai Aug-25 InfoBionic.Ai received FDA 510(k) clearance for its MoMe ARC 1-lead patch, introducing an extended-duration configuration for continuous ECG data collection. The clearance strengthens the company’s remote cardiac monitoring portfolio and supports expanded use in long-term arrhythmia detection and digital cardiac care workflows.
Clario Jun-24 Clario obtained FDA 510(k) clearance for its SpiroSphere integrated with the wireless COR-12 ECG device, enhancing remote cardiac data capture capabilities in decentralized clinical trial settings. The development supports improved physiologic monitoring integration and expands Clario’s role in digital clinical research infrastructure.
Wellysis Mar-24 Wellysis, a Samsung spin-off, launched a remote cardiac monitoring system in the U.S. in partnership with Artella Solutions. The initiative expands deployment of wearable ECG-enabled remote monitoring solutions, supporting broader adoption of connected cardiac care technologies in outpatient and remote healthcare environments.
Infobionic Oct-23 Infobionic received FDA clearance for its next-generation MoMe ARC remote ECG monitoring solution designed for arrhythmia detection and chronic disease management. The clearance strengthens its position in virtual cardiac care by enhancing continuous monitoring capabilities and supporting expanded clinical use of remote diagnostic workflows.
SmartCardia Sep-23 SmartCardia received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform enabling continuous monitoring for up to 14 days. The approval enhances its remote cardiac monitoring capabilities and supports broader adoption of multi-lead wearable ECG systems in ambulatory and clinical care environments.
VivaLNK, Inc. May-23 VivaLNK launched an updated multi-parameter wearable ECG patch designed to enable continuous 14-day livestream cardiac monitoring. The device is positioned to improve patient comfort while reducing administrative workload for clinical teams, supporting broader adoption of long-duration remote cardiac monitoring solutions in mobile ECG device applications.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Mobile ECG Devices Market — Custom Segments

Segment Sub-Segment
Technology Resting ECG, Holter Monitoring, Mobile Cardiac Telemetry, Patch-Based ECG
Connectivity Bluetooth, Cellular, Wi-Fi, Other Connectivity
Monitoring Duration Short-Term Monitoring, Extended Monitoring, Continuous Monitoring

Mobile ECG Devices Market — Custom TOC

Custom Chapter Chapter Details
Remote Cardiac Monitoring Adoption Roadmap
  • Evolution of Remote Cardiac Care Models
  • Clinical Adoption Across Care Settings
  • Patient Engagement and Home-Based Monitoring Trends
  • Future Adoption Trajectory
Digital Health Integration Opportunities
  • Integration with Digital Health Ecosystems
  • Interoperability with Healthcare Information Systems
  • AI-Enabled Clinical Decision Support
  • Connected Care Partnership Landscape
  • Digital Transformation Priorities
Reimbursement and Coverage Landscape
  • Coverage Policy Evolution
  • Public and Private Payer Perspectives
  • Reimbursement Drivers and Adoption Impact
  • Market Access Considerations
  • Regional Policy Variations

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current size of the mobile ECG devices market?

The market revenue for mobile ECG devices is anticipated at USD 3.72 billion in 2027.

What is the projected value of the mobile ECG devices industry by 2036?

Mobile ECG Devices Market size was worth USD 3.4 billion in 2026 and is expected to grow at a 11.12% CAGR between 2027 and 2036, surpassing USD 9.76 billion by 2036.

What is driving the shift toward homecare-based cardiac monitoring in the mobile ECG devices market?

Homecare adoption is increasing due to the need for continuous and symptom-driven cardiac monitoring outside clinical facilities. It enables patients to capture ECG data during daily life, improving diagnostic visibility while reducing dependence on repeated hospital or diagnostic center visits.

How are wearable band-based ECG devices changing cardiac monitoring behavior compared with traditional handheld formats?

Band devices support continuous, less intrusive ECG tracking during everyday activities, unlike handheld tools that capture intermittent readings. This shift is encouraging more sustained monitoring patterns and aligning with growing demand for wearable, patient-friendly cardiac observation solutions.

Why are Hospitals and Diagnostic Centers the largest end-use segment in the mobile ECG devices market?

Hospitals and Diagnostic Centers accounted for 51.62% of the market in 2026 due to high cardiac assessment volumes, structured diagnostic workflows, and access to trained clinicians for reliable ECG evaluation.

Which modality is growing the fastest in the mobile ECG devices market?

Band devices are the fastest-growing modality because they enable continuous, wearable ECG monitoring during daily activities, offering greater convenience than intermittent handheld assessments.

Why does North America dominate the mobile ECG devices market?

North America held a 51.41% share in 2026 due to mature connected healthcare infrastructure, widespread remote cardiac monitoring, and strong integration of portable ECG devices into clinical and home-based care.

What factors are driving mobile ECG device adoption in Asia Pacific?

Asia Pacific is projected to grow at a 12.99% CAGR, supported by expanding digital health services, greater healthcare technology access, and rising demand for flexible cardiac monitoring beyond hospitals.

Who are the leading players in the mobile ECG devices landscape?

Leading companies in the mobile ECG devices market include Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Medtronic plc (Ireland), iRhythm Technologies, Inc. (United States), Nihon Kohden Corporation (Japan), Omron Healthcare Co., Ltd. (Japan), AliveCor, Inc. (United States), Withings S.A. (France), EMAY Ltd. (China), Dr Trust (India).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Read our Research Approach →

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →